Curated News
By: NewsRamp Editorial Staff
April 12, 2024
Game-Changing Tumor-Freezing Technology Offers Minimally Invasive Alternative to Breast Lumpectomy
TLDR
- IceCure Medical Ltd. may set a new standard of care for early-stage breast cancer, potentially gaining a competitive advantage in the medical community.
- ProSense® cryoablation therapy for breast cancer uses liquid-nitrogen-based freezing to destroy diseased tissue, providing a minimally invasive treatment option.
- IceCure's ProSense® offers a non-surgical alternative to traditional lumpectomy, potentially improving the quality of life for women facing early-stage breast cancer.
- Cryoablation therapy, likened to a dental visit, has emerged as an appealing alternative to surgery for breast cancer, potentially revolutionizing treatment methods.
Impact - Why it Matters
IceCure's potential new standard of care for early-stage breast cancer has the potential to reduce the need for invasive surgeries, lower the economic burden on patients and medical providers, and provide a more attractive alternative for women facing this diagnosis. If approved by the FDA, this technology could significantly impact the treatment options available to women across America and potentially change the landscape of breast cancer care.
Summary
IceCure Medical Ltd. (NASDAQ: ICCM) is set to submit results from the largest cryoablation study of its kind to the FDA, potentially setting a new standard of care for early-stage breast cancer. The study found that cryoablation therapy may offer a minimally invasive alternative to surgery for women who elect not to have surgery, reducing the need for secondary procedures and improving recovery time. IceCure's ProSense procedure for breast tumors has shown promising topline results, with a 96.39% recurrence-free rate and no significant device-related adverse events reported.
Source Statement
This curated news summary relied on content disributed by News Direct. Read the original source here, Game-Changing Tumor-Freezing Technology Offers Minimally Invasive Alternative to Breast Lumpectomy
